Sourced from the European Cancer Organisation’s latest official updates on LinkedIn, a wave of major initiatives, clinical forums, and research opportunities has been launched to unify and strengthen cancer care across the continent. Whether you are a clinician looking to foster interdisciplinary collaboration, a junior researcher ready to present on a major international stage, or an advocate tracking national screening policies, here are the latest essential updates, deadlines, and insights you need to know.
“Three EU-funded projects and one shared goal: strengthening age-appropriate cancer care for adolescents and young adults (AYAs) across Europe.
The online Joint AYA Stakeholder Forum will bring together:
- PanCare4AYA, advancing survivorship care
- PredictAYA, improving understanding of long-term and reproductive health outcomes
- STRONG AYA, strengthening care through core outcomes and data-driven approaches
Join the discussion on Tuesday 30 June, 15:00-17:00 CEST.
The INTERACT-EUROPE 100 Enhanced Final Programme is now accepting applications!
Cancer centres across Europe are invited to join the final implementation cycle of INTERACT EUROPE 100, supporting interdisciplinary collaboration and excellence in patient-centred cancer care.
Following the project’s successful previous iteration – with 107 cancer centres across 26 countries and more than 1,100 healthcare professionals enrolled – the enhanced edition offers a more focused learning experience, tailored online and onsite opportunities, micro-credentials where applicable, and access to a growing European network advancing interdisciplinary oncology education.
Participation is free of charge for eligible organizations.
If you’ve been waiting for a sign, this is it.
If you are a junior (under 40) cancer researcher or academic, this is your chance to share your work on a major European stage.
Submit your abstract by 31 July, 17:00 CEST.
Selected abstracts will be featured in the exhibition area at the European Cancer Summit on 18 and 9 November – with top authors invited to present their work live on stage in front of Europe’s leading oncology experts.
So don’t hesitate.
Find more information and submit your abstract.
The numbers are still much too high, but cancer mortality is on a steady decline in Europe. This is thanks to innovative treatments, prevention policies and organized screening programmes.
But this progress is not shared equally.
The newly updated European Cancer Screening Policy Index reveals persistent gaps between countries, with clear regional divides in access and performance.
Pulling from these findings, the European Cancer Organisation urges national governments to:
- Align with EU screening ambitions
- Strengthen data-driven collaboration
- Improve and modernize screening programmes
- Prioritize early detection across health systems
Curious how your country scores and what can be improved? Download the Index now.
Women’s cancer needs must be part of the wider cancer care agenda.
At the European Conference of Oncology Pharmacy (ECOP) 7, Dominika Kormanová, Europa Donna representative and member of ECO’s Patient Advisory Committee, will contribute to a dedicated Women and Cancer session hosted by the European Society of Oncology Pharmacy.
The session will highlight why integrating gender into cancer policy and care is essential for better outcomes, greater equity and stronger collaboration across the cancer community.
The session builds on ECO’s Women and Cancer workstream, including insights from the ‘12 Million Reasons for Action’ policy report and the Women and Cancer Policy Index.
Thank you to European Society of Oncology Pharmacy (ESOP), an ECO Member Society, for creating space for this timely exchange.
Discover how Europe is performing on gender-sensitive cancer policy through ECO’s Women and Cancer Policy Index.”
